StonvexLoading…
StonvexStonvexStonvexCore line items from CAN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $529.74M | $269.32M | $211.48M | $651.53M |
Operating Income | $-112.23M | $-227.13M | $-410.88M | $42.94M |
Net Income | $-210.27M | $-249.75M | $-414.15M | $69.88M |
EPS (Diluted) | $-2.99 | $-6.13 | $-16.06 | $2.71 |
Total Assets | $602.88M | $463.01M | $493.30M | $684.96M |
Total Liabilities | $165.52M | $196.76M | $145.11M | $77.30M |
Cash & Equivalents | $80.78M | $96.49M | $96.15M | $707.26M |
Free Cash Flow OCF − CapEx | $-295.83M | $-218.57M | $-126.93M | $-200.35M |
Shares Outstanding | 7.04B | 4.61B | 3.51B | 2.50B |